학술논문
First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI study
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15323080